AAD 2020: Investigational Bimekizumab Outperforms Ustekinumab in Plaque Psoriasis
The new agent may push treatment goals for plaque psoriasis to new targets
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.